Biogen Reports 2016 Revenues of $11.4 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Wall St ends lower for the day and week as chip selloff broadens
Biogen (BIIB) Tops Q4 EPS by 8c; FY17 Rev Guidance Falls Below the Street
January 26, 2017 6:32 AM ESTBiogen (NASDAQ: BIIB) reported Q4 EPS of $5.04, $0.08 better than the analyst estimate of $4.96. Revenue for the quarter came in at $2.87 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Biogen sees FY2017 EPS of $20.45-$21.45, versus the consensus of $21.02. Biogen sees FY2017 revenue of $11.1-11.4 billion, versus the consensus of $12.07 billion.
"
Biogen seeks to advance transformational... More
